Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10259-10266

  Shen, Huimin ^a   Cai, Muyan ^a   Zhao, Shanshan ^a   Wang, Huan ^a   Li, Mengxiong ^a   Yao, Shuzhong ^a   Jiang, Nan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biomarker; Diagnose; Ovarian carcinoma; Prognostic; Replication factor C

Indexed keywords

REPLICATION FACTOR C; RFC3 PROTEIN, HUMAN; TUMOR MARKER;

BIOSYNTHESIS; CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPLICATION PROTEIN C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84922391971     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2216-2     Document Type: Article

References (35)

1. Atlanta: American Cancer Society; American Cancer Society. Cancer Facts & Figures 2012. National Home Office; 2012.
2. Kurman RJ, Shih IM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.
3. Gomez-Raposo C, Mendiola M, Barriuso J, Hardisson D, Redondo A. Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol. 2010;118:88–92.
4. Ricciardelli C, Oehler MK. Diverse molecular pathways in ovarian cancer and their clinical significance. Maturitas. 2009;62:270–5.
5. Bast Jr RC, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9:415–28.
6. Vaughan S, Coward JI, Bast Jr RC, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11:719–25.
7. Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519–29.
8. Lee SH, Kwong AD, Ishimi Y, Hurwitz J. Studies on the DNA elongation inhibitor and its proliferating cell nuclear antigen-dependent control in simian virus 40 DNA replication in vitro. Proc Natl Acad Sci U S A. 1989;86:4877–81.
9. Tsurimoto T, Stillman B. Purification of a cellular replication factor, RF-C, that is required for coordinated synthesis of leading and lagging strands during simian virus 40 DNA replication in vitro. Mol Cell Biol. 1989;9:609–19.
10. Shimada M, Okuzaki D, Tanaka S, et al. Replication factor C3 of Schizosaccharomyces pombe, a small subunit of replication factor C complex, plays a role in both replication and damage checkpoints. Mol Biol Cell. 1999;10:3991–4003.
11. Kim HS, Brill SJ. Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae. Mol Cell Biol. 2001;21:3725–37.
12. Fien K, Stillman B. Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex. Mol Cell Biol. 1992;12:155–63.
13. Li X, Burgers PM. Molecular cloning and expression of the Saccharomyces cerevisiae RFC3 gene, an essential component of replication factor C. Proc Natl Acad Sci U S A. 1994;91:868–72.
14. Luckow B, Bunz F, Stillman B, Lichter P, Schutz G. Cloning, expression, and chromosomal localization of the 140-kilodalton subunit of replication factor C from mice and humans. Mol Cell Biol. 1994;14:1626–34.
15. Cullmann G, Fien K, Kobayashi R, Stillman B. Characterization of the five replication factor C genes of Saccharomyces cerevisiae. Mol Cell Biol. 1995;15:4661–71.
16. Gray FC, MacNeill SA. The Schizosaccharomyces pombe rfc3+ gene encodes a homologue of the human hRFC36 and Saccharomyces cerevisiae Rfc3 subunits of replication factor C. Curr Genet. 2000;37:159–67.
17. Mossi R, Hubscher U. Clamping down on clamps and clamp loaders—the eukaryotic replication factor C. Eur J Biochem/FEBS. 1998;254:209–16.
18. Anderson LA, Perkins ND. The large subunit of replication factor C interacts with the histone deacetylase, HDAC1. J Biol Chem. 2002;277:29550–4.
19. Anderson LA, Perkins ND. Regulation of RelA (p65) function by the large subunit of replication factor C. Mol Cell Biol. 2003;23:721–32.
20. Koch HB, Zhang R, Verdoodt B, et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle (Georgetown, Tex). 2007;6:205–17.
21. Arai M, Kondoh N, Imazeki N, et al. The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells. Liver Int: Off J Int Assoc Study Liver. 2009;29:55–62.
22. Jung HM, Choi SJ, Kim JK. Expression profiles of SV40-immortalization-associated genes upregulated in various human cancers. J Cell Biochem. 2009;106:703–13.
23. Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer. 2007;43:415–32.
24. Xiong S, Wang Q, Zheng L, Gao F, Li J. Identification of candidate molecular markers of nasopharyngeal carcinoma by tissue microarray and in situ hybridization. Med Oncol. 2011;28 Suppl 1:S341–8.
25. Lockwood WW, Thu KL, Lin L, et al. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma. Clin Cancer Res: Off J Am Assoc Cancer Res. 2012;18:1936–46.
26. Li Y, Yang HX, Luo RZ, et al. High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91:1531–8.
27. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol. 2007;60:1112–6.
28. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: Cancer J Clin. 2011;61:212–36.
29. Badgwell D, Bast Jr RC. Early detection of ovarian cancer. Dis Markers. 2007;23:397–410.
30. Bast Jr RC. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare. Trans Am Clin Climatol Assoc. 2004;115:233–47. discussion 47-8.
31. Branzei D, Foiani M. Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol. 2010;11:208–19.
32. Mac SM, D'Cunha CA, Farnham PJ. Direct recruitment of N-myc to target gene promoters. Mol Carcinog. 2000;29:76–86.
33. Oliver TG, Grasfeder LL, Carroll AL, et al. Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci U S A. 2003;100:7331–6.
34. Spurgers KB, Gold DL, Coombes KR, et al. Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem. 2006;281:25134–42.
35. Vernell R, Helin K, Muller H. Identification of target genes of the p16INK4A-pRB-E2F pathway. J Biol Chem. 2003;278:46124–37.